Related Experiment Video
Updated: Feb 24, 2026

05:19
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
3.5K
Non-Invasively Targeting, Probing, and Modulating a Deep Brain Circuit for Depression Alleviation
Desmond J Oathes1,2, Romain J-P Duprat1, Justin Reber1
1Department of Psychiatry, Center for Neuromodulation in Depression and Stress, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Nature. Mental Health
|February 23, 2026
Summary
Repetitive transcranial magnetic stimulation (rTMS) effectively treats depression by engaging brain circuits. This study shows that TMS-evoked responses in the subgenual anterior cingulate cortex (sgACC) predict clinical improvement in depression patients.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Imaging
Background:
- Repetitive transcranial magnetic stimulation (rTMS) is a promising depression treatment.
- Focus has been on modulating the subgenual anterior cingulate cortex (sgACC).
- No prior studies linked sgACC TMS-evoked responses to clinical outcomes.
Purpose of the Study:
- To demonstrate sgACC circuit engagement using TMS-evoked responses.
- To investigate the relationship between sgACC TMS-evoked responses and clinical effects of rTMS for depression.
- To establish causal evidence of sgACC engagement and its clinical relevance.
Main Methods:
- Used interleaved single-pulse TMS/fMRI in 36 unmedicated depressed patients.
- Identified sgACC-connected cortical targets using rs-fMRI.
- Assessed TMS-evoked fMRI BOLD responses in sgACC before and after a 3-day iTBS rTMS intervention.
Main Results:
- Pre-intervention sgACC TMS-evoked response magnitude predicted depression improvement.
- More negative evoked responses correlated with greater clinical improvement.
- Post-intervention changes in evoked responses also associated with depression improvement, specific to the targeted pathway.
Conclusions:
- Demonstrated causal evidence of sgACC engagement via TMS/fMRI.
- Showed the clinical relevance of engaging and modulating the prefrontal-sgACC circuit.
- TMS-evoked responses in sgACC serve as a prognostic biomarker for rTMS treatment in depression.

